Celldex Therapeutics (CLDX) PT Raised to $72 at Wells Fargo
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $39.12 -1.41%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $72.00 (from $48.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Celldex to Present at Upcoming Investor Conference
- Pharvaris B.V. (PHVS) PT Raised to $75 at Oppenheimer
- Pharvaris B.V. (PHVS) PT Raised to $65 at Cantor Fitzgerald
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
